Description
Myteka 5mg contains Montelukast, a highly effective leukotriene receptor antagonist, specifically formulated as chewable tablets for children, typically aged 6 to 14 years. Each tablet delivers 5mg of Montelukast, which works by blocking inflammatory substances in the body that cause airway narrowing and mucus production. This medication is crucial for the prevention and chronic treatment of asthma symptoms, helping to reduce the frequency and severity of asthma attacks. It also effectively alleviates symptoms of seasonal and perennial allergic rhinitis, such as sneezing, nasal congestion, and itching, ensuring children experience improved respiratory comfort and fewer allergy-related discomforts for better daily living.
